Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Jan;83(1):39–42. doi: 10.1136/bjo.83.1.39

High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease

N Yawata 1, S Nakamura 1, M Kijima 1, N Ikai 1, M Kanai 1, M Sugita 1, S Ohno 1
PMCID: PMC1722769  PMID: 10209432

Abstract

AIMS—To evaluate glucose tolerance of patients with Vogt-Koyanagi-Harada (VKH) disease before systemic corticosteroid therapy, and to assess changes brought on by treatment.
METHODS—20 VKH patients with acute bilateral panuveitis were studied. 20 healthy adults and 11 Behçet's disease patients with active uveoretinitis served as controls. A 75 g oral glucose tolerance test (OGTT) was given in the acute stage of ocular inflammation before systemic corticosteroid therapy. The OGTT was repeated in the convalescent stage of VKH disease in the patients with glucose intolerance before treatment. Insulin response was examined at the same time as the OGTT when possible.
RESULTS—55% of VKH patients (11/20) showed glucose intolerance but no apparent insulin secretion deficiency was detected. Four of seven patients in the convalescent stage showed improvement of glucose tolerance. None of the normal controls or disease controls showed glucose intolerance.
CONCLUSION—A high incidence of glucose intolerance was found in the acute stage of VKH disease. However, glucose intolerance improved in most cases after systemic corticosteroid therapy. It is possible that glucose intolerance seen in VKH patients may be related to the autoimmune inflammatory process of this disease.

 Keywords: glucose intolerance; Vogt-Koyanagi-Harada disease

Full Text

The Full Text of this article is available as a PDF (90.4 KB).

Figure 1  .

Figure 1  

Open in a new tab

Clinical score of ocular inflammation in VKH disease. Active inflammation is classified into 5 degrees from score 0 to score 4. AC=anterior chamber; KPs=keratic precipitates.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beisel W. R. Metabolic response to infection. Annu Rev Med. 1975;26:9–20. doi: 10.1146/annurev.me.26.020175.000301. [DOI] [PubMed] [Google Scholar]
  2. Beniz J., Forster D. J., Lean J. S., Smith R. E., Rao N. A. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina. 1991;11(3):275–280. doi: 10.1097/00006982-199111030-00001. [DOI] [PubMed] [Google Scholar]
  3. Besedovsky H. O., Del Rey A. Metabolic and endocrine actions of interleukin-1. Effects on insulin-resistant animals. Ann N Y Acad Sci. 1990;594:214–221. doi: 10.1111/j.1749-6632.1990.tb40481.x. [DOI] [PubMed] [Google Scholar]
  4. Chan C. C., Palestine A. G., Nussenblatt R. B., Roberge F. G., Benezra D. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology. 1985 Aug;92(8):1025–1028. doi: 10.1016/s0161-6420(85)33911-8. [DOI] [PubMed] [Google Scholar]
  5. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979 Dec;28(12):1039–1057. doi: 10.2337/diab.28.12.1039. [DOI] [PubMed] [Google Scholar]
  6. Drobny E. C., Abramson E. C., Baumann G. Insulin receptors in acute infection: a study of factors conferring insulin resistance. J Clin Endocrinol Metab. 1984 Apr;58(4):710–716. doi: 10.1210/jcem-58-4-710. [DOI] [PubMed] [Google Scholar]
  7. Jaggarao N., Voth D., Jacobsen J. The Vogt-Koyanagi-Harada syndrome: association with hypothyroidism and diabetes mellitus. Postgrad Med J. 1989 Aug;65(766):587–588. doi: 10.1136/pgmj.65.766.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KUMAGAI A., MORIMOTO Y., YAMAMURA Y. MAJOR SIDE-EFFECTS OF GLUCOCORTICOIDS IN JAPAN. Endocrinol Jpn. 1965 Mar;12:36–46. doi: 10.1507/endocrj1954.12.36. [DOI] [PubMed] [Google Scholar]
  9. Koivisto V. A., Pelkonen R., Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes. 1989 May;38(5):641–647. doi: 10.2337/diab.38.5.641. [DOI] [PubMed] [Google Scholar]
  10. Maezawa N., Yano A., Taniguchi M., Kojima S. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease. Ophthalmologica. 1982;185(3):179–186. doi: 10.1159/000309240. [DOI] [PubMed] [Google Scholar]
  11. Ohno S. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases. Trans Ophthalmol Soc U K. 1981 Sep;101(3):335–341. [PubMed] [Google Scholar]
  12. Ohno S., Kato F., Matsuda H., Fujii N., Minagawa T. Studies on spontaneous production of gamma-interferon in Behçet's disease. Ophthalmologica. 1982;185(3):187–192. doi: 10.1159/000309241. [DOI] [PubMed] [Google Scholar]
  13. Panina-Bordignon P., Lang R., van Endert P. M., Benazzi E., Felix A. M., Pastore R. M., Spinas G. A., Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med. 1995 May 1;181(5):1923–1927. doi: 10.1084/jem.181.5.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sasamoto Y., Ohno S., Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica. 1990;201(3):162–167. doi: 10.1159/000310145. [DOI] [PubMed] [Google Scholar]
  15. Shindo Y., Ohno S., Yamamoto T., Nakamura S., Inoko H. Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol. 1994 Mar;39(3):169–176. doi: 10.1016/0198-8859(94)90257-7. [DOI] [PubMed] [Google Scholar]
  16. Svenson K. L., Pollare T., Lithell H., Hällgren R. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism. 1988 Feb;37(2):125–130. doi: 10.1016/s0026-0495(98)90005-1. [DOI] [PubMed] [Google Scholar]
  17. Todd J. A. Genetic control of autoimmunity in type 1 diabetes. Immunol Today. 1990 Apr;11(4):122–129. doi: 10.1016/0167-5699(90)90049-f. [DOI] [PubMed] [Google Scholar]
  18. Tsokos G. C., Gorden P., Antonovych T., Wilson C. B., Balow J. E. Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors. Ann Intern Med. 1985 Feb;102(2):176–181. doi: 10.7326/0003-4819-102-2-176. [DOI] [PubMed] [Google Scholar]
  19. YALOW R. S., BERSON S. A. Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic. Diabetes. 1960 Jul-Aug;9:254–260. doi: 10.2337/diab.9.4.254. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES